Potent EGFR tyrosine kinase inhibitors as anticancer agents

被引：0
|
作者：
Shiao, Hui-Yi [1 ]
Chu, Chang-Ying [1 ]
Hsu, John T. -A. [1 ]
Yeh, Teng-Kuang [1 ]
Hsieh, Hsing-Pang [1 ]
机构：
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Miaoli, Taiwan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 241卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
257-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
    Kobayashi, Susumu
    Canepa, Hannah M.
    Bailey, Alexandra S.
    Nakayama, Sohei
    Yamaguchi, Norihiro
    Goldstein, Michael A.
    Huberman, Mark S.
    Costa, Daniel B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) : 118 - 122
  • [22] Management of Resistance to EGFR Tyrosine Kinase Inhibitors
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S82 - S83
  • [23] Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor SubfamilyRole as Anticancer Agents
    Sarah B. Noonberg
    Christopher C. Benz
    Drugs, 2000, 59 : 753 - 767
  • [24] Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors
    Zhang, Jingxian
    Jia, Jia
    Zhu, Feng
    Ma, Xiaohua
    Han, Bucong
    Wei, Xiaona
    Tan, Chunyan
    Jiang, Yuyang
    Chen, Yuzong
    MOLECULAR BIOSYSTEMS, 2012, 8 (10) : 2645 - 2656
  • [25] DESIGN AND SYNTHESIS OF NEW EGFR- TYROSINE KINASE INHIBITORS CONTAINING PYRAZOLO[3,4-d]PYRIMIDINE CORES AS ANTICANCER AGENTS
    Bakr, Rania B.
    Abdelall, Eman K. A.
    Abdel-Hamid, Mohamed K.
    Kandeel, Manal M.
    BULLETIN OF PHARMACEUTICAL SCIENCES, 2012, 35 : 27 - 42
  • [26] New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells
    Tandon, Manuj
    Johnson, James
    Li, Zhihong
    Xu, Shuping
    Wipf, Peter
    Wang, Qiming Jane
    PLOS ONE, 2013, 8 (09):
  • [27] Sulfonylated Indeno[1,2-c]quinoline Derivatives as Potent EGFR Tyrosine Kinase Inhibitors
    Hengphasatporn, Kowit
    Aiebchun, Thitinan
    Mahalapbutr, Panupong
    Auepattanapong, Atima
    Khaikate, Onnicha
    Choowongkomon, Kiattawee
    Kuhakarn, Chutima
    Meesin, Jatuporn
    Shigeta, Yasuteru
    Rungrotmongkol, Thanyada
    ACS OMEGA, 2023, 8 (22): : 19645 - 19655
  • [28] Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily - Role as anticancer agents
    Noonberg, SB
    Benz, CC
    DRUGS, 2000, 59 (04) : 753 - 767
  • [29] Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment
    Ma, Chenchen
    Cui, Siyuan
    Xu, Ruirong
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (29) : 4657 - 4686
  • [30] Potent 4-anilinoquinazoline inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase.
    Ghosh, S
    Liu, XP
    Narla, RK
    Jun, X
    Mao, C
    Uckun, FM
    CLINICAL CANCER RESEARCH, 1999, 5 : 3750S - 3750S
12345